Mount Sinai researchers highlight artificial intelligence's role in evidence-based medicine, emphasizing ChatGPT-4's autonomous clinical capabilities and acknowledging operational challenges.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok